Regulatory T cells and tolerogenic dendritic cells: From basic biology to clinical applications

Immunology Letters

Volumn 94, Issue 1-2, 2004, Pages 11-26

  Rutella, Sergio ^a   Lemoli, Roberto M ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

G CSF; IL 10; Regulatory T cell; TGF ; Tolerogenic dendritic cell

Indexed keywords

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 3242677783     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.04.015     Document Type: Review

References (127)

1. Roncarolo M.G., Levings M.K., Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:2001;F5-F9
2. Von Herrath M.G., Harrison L.C. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3:2003;223-232
3. Jonuleit H., Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171:2003;6323-6327
4. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:2003;685-711
5. Morelli A.E., Thomson A.W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196:2003;125-146
6. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:2001;1285-1294
7. + T cells with regulatory properties from human blood. J. Exp. Med. 193:2001;1303-1310
8. + human thymocytes. J. Exp. Med. 196:2002;379-387
9. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5:2004;266-271
10. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389-400
11. Bach J.F. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3:2003;189-198
12. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172:2004;3983-3988
13. + regulatory T cells in the absence of STAT1: Increased susceptibility to autoimmune disease. J. Exp. Med. 199:2004;25-34
14. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:2003;3435-3441
15. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:2002;135-142
16. + regulatory T cells. J. Immunol. 171:2003;5678-5682
17. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:2001;68-73
18. + regulatory T cells by TGF-β induction of transcription factor FoxP3. J. Exp. Med. 198:2003;1875-1886
19. - T cells. J. Clin. Invest. 112:2003;1437-1443
20. Bruder D., Probst-Kepper M., Westendorf A.M., Geffers R., Beissert S., Loser K., von Boehmer H., Buer J., Hansen W. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34:2004;623-630
21. + regulatory T cells is mediated by cell surface-bound transforming growth factor β J. Exp. Med. 194:2001;629-644
22. + regulatory T cells from human peripheral blood. J. Immunol. 166:2001;7282-7289
23. + T helper cells. J. Exp. Med. 196:2002;255-260
24. + regulatory T cells and infectious tolerance. Transplantation. 77:2004;S23-S25
25. + T cells. Int. Immunol. 12:2000;177-185
26. Yvon E.S., Vigouroux S., Rousseau R.F., Biagi E., Amrolia P., Dotti G., Wagner H.J., Brenner M.K. Overexpression of the notch ligand, jagged-1, induces alloantigen-specific human regulatory T cells. Blood. 102:2003;3815-3821
27. + regulatory T cells. J. Exp. Med. 194:2001;847-853
28. Weiner H.L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182:2001;207-214
29. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742
30. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol. Rev. 182:2001;68-79
31. - T cells to acquire regulatory cell function. Blood. 101:2003;5076-5083
32. Zelenika D., Adams E., Humm S., Graca L., Thompson S., Cobbold S.P., Waldmann H. Regulatory T cells overexpress a subset of Th2 gene transcripts. J. Immunol. 168:2002;1069-1079
33. Cobbold S.P., Nolan K.F., Graca L., Castejon R., Le Moine A., Frewin M., Humm S., Adams E., Thompson S., Zelenika D., Paterson A., Yates S., Fairchild P.J., Waldmann H. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol. Rev. 196:2003;109-124
34. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172:2004;4676-4680
35. + regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30:2000;1538-1543
36. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:2002;1335-1346
37. Levings M.K., Bacchetta R., Schulz U., Roncarolo M.G. The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 129:2002;263-276
38. Bacchetta R., Sartirana C., Levings M.K., Bordignon C., Narula S., Roncarolo M.G. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol. 32:2002;2237-2245
39. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., Roncarolo M.G. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:2001;5530-5539
40. Wolf A.M., Wolf D., Steurer M., Gastl G., Gunsilius E., Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9:2003;606-612
41. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61:2001;4766-4772
42. + regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β Cancer Res. 62:2002;5267-5272
43. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., Linehan D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169:2002;2756-2761
44. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163:1999;5211-5218
45. + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 34:2004;336-344
46. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 363:2004;608-615
47. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:1997;3245-3287
48. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:2002;445-449
49. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Immunity. 101:2000;455-458
50. Benichou G., Valujskikh A., Heeger P.S. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162:1999;352-358
51. Lechler R., Ng W.F., Steinman R.M. Dendritic cells in transplantation - friend or foe? Immunity. 14:2001;357-368
52. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal-Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283:1999;1183-1186
53. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2:2001;585-589
54. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., Schmitz J. BDCA-2, BDCA-3 and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:2000;6037-6046
55. Pulendran B., Banchereau J., Maraskovsky E., Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:2001;41-47
56. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837
57. Mazzoni A, Segal DM. Controlling the toll road to dendritic cell polarization. J Leukoc Biol 2004 (published on-line January 14, 2004).
58. Kadowaki N., Ho S., Antonenko S., de Waal Malefyt R., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869
59. Ardavin C., Martinez del Hoyo G., Martin P., Anjuere F., Arias C.F., Marin A.R., Ruiz S., Parrillas V., Hernandez H. Origin and differentiation of dendritic cells. Trends Immunol. 22:2001;691-700
60. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109-1118
61. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261
62. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185:1997;1101-1111
63. Woltman A.M., van Kooten C. Functional modulation of dendritic cells to suppress adaptive immune responses. J. Leukoc. Biol. 73:2003;428-441
64. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:2003;235-247
65. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T-cell areas of mesenteric lymph nodes. J. Exp. Med. 191:2000;435-444
66. Menges M., Rossner S., Voigtlander C., Schindler H., Kukuysch N.A., Bogdan C., Erb K., Schuler G., Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor-α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:2002;15-21
67. Akbari O., De Kruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:2001;725-731
68. Legge K.L., Gregg R.K., Maldonado-Lopez R., Li L., Caprio J.C., Moser M., Zaghouani H. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196:2002;217-227
69. Zheng Y., Manzotti C.N., Liu M., Burke F., Mead K.I., Sansom D.M. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172:2004;2778-2784
70. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4:2004;24-34
71. Sato K., Yamashita N., Baba M., Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood. 101:2003;3581-3589
72. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222
73. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238
74. Sato K., Yamashita N., Yamashita N., Masanori B., Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity. 18:2003;367-379
75. Wakkach A., Fuornier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 18:2003;605-617
76. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:2002;603-616
77. Gray C.P., Arosio P., Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood. 99:2002;3326-3334
78. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:2002;447-457
79. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L., Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:2003;1206-1212
80. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., Marshall B., Chandler P., Antonia S.J., Burgess R., Slingluff C.L., Mellor A.L. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 297:2002;1867-1870
81. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172:2004;4100-4110
82. S cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:2002;237-243
83. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., Mancini D., Suciu-Foca N. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11:2003;245-258
84. Martin E., O'Sullivan B., Low P., Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 18:2003;155-167
85. Rutella S., Rumi C., Sica S., Leone G. Recombinant human granulocyte colony-stimulating factor (rhG-CSF): effects on lymphocyte phenotype and function. J. Interferon Cytokine Res. 19:1999;989-994
86. Volpi I., Perruccio K., Tosti A., Capanni M., Ruggeri L., Posati S., Aversa F., Tabilio A., Romani L., Martelli M.F., Velardi A. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood. 97:2001;2514-2521
87. Zavala F., Abad S., Ezine S., Taupin V., Masson A., Bach J.F. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168:2002;2011-2019
88. high blood dendritic cells with altered CD62L and CCR7 expression. Blood. 101:2003;2314-2317
89. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., Anasetti C. Granulocyte colony-stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 95:2000;2484-2490
90. Radcliff F.J., Caruso D.A., Koina C., Riordan M.J., Roberts A.W., Tang M.L., Baum C.M., Woulfe S.L., Ashley D.M. Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy. Br. J. Haematol. 119:2002;204-211
91. Rutella S., Pierelli L., Rumi C., Bonanno G., Marone M., Sica S., Capoluongo E., Ameglio F., Scambia G., Leone G. T-cell apoptosis induced by granulocyte colony-stimulating factor (G-CSF) is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp. Hematol. 29:2001;401-415
92. Rutella S., Rumi C., Lucia M.B., Sica S., Cauda R., Leone G. Serum of healthy donors receiving recombinant human granulocyte colony-stimulating factor (rhG-CSF) induces T-cell unresponsiveness. Exp. Hematol. 26:1998;1024-1033
93. Franzke A., Piao W., Lauber J., Gatzlaff P., Koneche C., Hansen W., Schmitt-Thomsen A., Hertenstein B., Buer J., Ganser A. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood. 102:2003;734-739
94. Rutella S., Pierelli L., Bonanno G., Sica S., Ameglio F., Capoluongo E., d'Onofrio G., Leone G. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 100:2002;2562-2571
95. Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo ED, Contemi AM, Ameglio F, Curti A, de Ritis DG, Voso MT, Perillo A, Scambia G, Lemoli RM, Leone G. Granulocyte colony-stimulating factor promotes the generation of regulatory DCs through induction of IL-10 and IFN-α. Eur J Immunol 2004;34:1291-302.
96. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6800-6805
97. Nouri-Shirazi M., Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation. 74:2002;1035-1044
98. Baker R.J., Hernandez-Fuentes M.P., Brookes P.A., Chaudhry A.N., Cook H.T., Lechler R.I. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J. Immunol. 167:2001;7199-7206
99. Morris E.S., Rowe V., Johnson D.H., Banovic T., Clouston A.D., Hill G.R. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood. 103:2004;3573-3581
100. MacDonald K.P., Rowe V., Filippich C., Thomas R., Clouston A.D., Welply J.K., Hart D.N., Ferrara J.L., Hill G.R. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood. 101:2003;2033-2042
101. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822
102. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:2004;971-979
103. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004 (published on-line May 3, 2004).
104. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:2003;199-210
105. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:2001;1295-1302
106. Rastellini C., Lu L., Ricordi C., Starzl T.E., Rao A.S., Thomson A.W. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation. 60:1995;1366-1370
107. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 62:1996;659-665
108. Lu L., Li W., Fu F., Chambers F.G., Qian S., Fung J.J., Thomson A.W. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 64:1997;1808-1815
109. + T cell tolerance. J. Exp. Med. 196:2002;1627-1638
110. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 101:2003;4862-4869
111. Mahnke K., Knop J., Enk A.H. Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol. 24:2003;646-651
112. + T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172:2004;1991-1995
113. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:2002;4712-4716
114. + regulatory T cells. J. Immunol. 170:2003;3939-3943
115. + immunoregulatory T cells: new therapeutics for graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:2002;401-406
116. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112:2003;1688-1696
117. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:2003;1144-1150
118. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:2002;389-399
119. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:2002;3493-3499
120. high regulatory T cells. Blood. 103:2004;2410-2416
121. Morelli A.E., Hackstein H., Thomson A.W. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13:2001;323-335
122. Sayegh M.H., Khoury S., Hancock W., Weiner H., Carpenter C. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7762-7766
123. Blankenstein T., Schuler T. Cross-priming versus cross-tolerance: are two signals enough? Trends Immunol. 23:2002;171-173
124. + T cells by human mature autologous dendritic cells. Eur. J. Immunol. 34:2004;762-772
125. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat. Immunol. 1:2000;305-310
126. Nestle F.O., Banchereau J., Hart D. Dendritic cells: on the move from bench to bedside. Nat. Med. 7:2001;761-765
127. + monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination. Br. J. Haematol. 121:2003;240-250